Four cases of mucosal neuroma syndrome: Multiple endocrine neoplasm 2B or not 2B?

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 17-20

  Gordon, Catherine M ^a   Majzoub, Joseph A ^a   Marsh, Debbie J ^b,c,d   Mulliken, John B ^a   Ponder, Bruce A J ^e,f   Robinson, Bruce G ^d   Eng, Charis ^b,c,e,g,h  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Clinical Research Center

^g Clinical Research Center ^*

^h Charles A Dana Foundation

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; ENDOCRINE TUMOR; FEMALE; GENE MUTATION; GERM LINE; HUMAN; LIGAND BINDING; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEURAL CREST; NEUROMA; PRIORITY JOURNAL; PROTO ONCOGENE; SOMATIC MUTATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PEDIGREE; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS;

EID: 0031738092     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.17     Document Type: Article

References (31)

1. Schimke RN. 1984 Genetic aspects of multiple endocrine neoplasia. Annu Rev Med. 35:25-31.
2. Eng C. 1996 The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung disease. N Engl J Med. 335:943-951.
3. Gagel RF, Tashjian AH, Cummings T, et al. 1988 The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. N Engl J Med. 318:478-484.
4. Vasen HFA, Lamers CBHW, Lips CJM. 1989 Screening for multiple endocrine neoplasia syndrome type 1. A study of 11 kindreds in the Netherlands. Arch Intern Med. 149:2717-2722.
5. Gorlin RJ, Sedano HO, Vickers RA, Cervenka J. 1968 Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid - a syndrome. Cancer. 22:293-299.
6. Raue F, Frank-Raue K, Grauer A. 1994 Multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am. 21:137-156.
7. Carney JA, Roth SI, Heth H, Sizemore GW, Hayla AB. 1980 The parathyroid glands in multiple endocrine neoplasia type 2b. Am J Pathol. 99:387-298.
8. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H. 1988 Cloning and expression of the RET proto-oncogene encoding a receptor tyrosine kinase with two potential transmembrane domains. Oncogene. 3:571-578.
9. Takahashi M, Buma Y, Hiai H. 1989 Isolation of RET proto-oncogene cDNA with an amino-terminal signal. Oncogene. 4:805-806.
10. Trupp M, Arenas E, Fainzilber M, et al. 1996 Functional receptor for GDNF encoded by the c-RET proto-oncogene. Nature. 381:785-789.
11. Jing S, Wen D, Yu Y, et al. 1996 GDNF-induced activation of the RET protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell. 85:1113-1124.
12. Vega QC, Worby CA, Lechner MS, Dixon JE, Dressler GR. 1996 Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci USA. 93:10657-10661.
13. Treanor JJS, Goodman L, de Sauvage F, et al. 1996 Characterization of a multicomponent receptor for GDNF. Nature. 382:80-83.
14. Buj-Bello A, Adu J, Pinon LGP, et al. 1997 Neurturin responsiveness requires a GPI-linked receptor and the RET receptor tyrosine kinase. Nature. 387:721-724.
15. Klein RD, Sherman D, Ho W-H, et al. 1997 A GPI-linked protein that interacts with RET to form a candidate neurturin receptor. Nature. 387:717-721.
16. Baloh RH, Tanset MG, Golden JP, et al. 1997 TrnR2, a novel receptor that mediates neurturin and GDNF signaling through RET. Neuron. 18:793-802.
17. Pachnis V, Mankoo B, Constantini F. 1993 Expression of the c-RET proto-oncogene during mouse embryogenesis. Development. 119:1005-1017.
18. Hofstra RMW, Landsvater RM, Ceccherini I, et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:375-376.
19. Eng C, Smith DP, Mulligan LM, et al. 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasin type 2B and related sporadic tumors. Hum Mol Genet. 3:237-241.
20. Carlson KM, Dou S, Chi D, et al. 1994 Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA. 91:1579-1583.
21. Eng C, Clayton D, Schuffenecker I, et al. 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium Analysis. JAMA. 276:1575-1579.
22. Mathew CGP, Smith BA, Thorp K, et al. 1987 Deletion of genes on chromosome 1 in endocrine neoplasia. Nature. 328:524-526.
23. Wright DK, Manos M. 1990 Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols. A guide to methods and application. San Diego: Harcourt, Brace, Jovanovich; 153-158.
24. Marsh DJ, Learoyd DL, Andrew SD, et al. 1996 Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf). 44:249-257.
25. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993 Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458-460.
26. Mulligan LM, Eng C, Healey CS, et al. 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6:70-74.
27. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 10:509-513.
28. Mulligan LM, Marsh DJ, Robinson BG, et al. 1995 Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med. 238:343-346.
29. Toogood AA, Eng C, Smith DP, Ponder BAJ, Shalet SM. 1995 No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B. Clin Endocrinol (Oxf). 43:759-762.
30. Edery P, Attie T, Amiel J, et al. 1996 Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet. 12:442-444.
31. Kusafuka T, Wang Y, Puri P. 1997 Mutation analysis of the RET, the endothelin-β receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung's disease. J Pediatr Surg. 32:501-504.